FDA Announces Two New Appointments
Susan C. Winckler has been named the agency's acting chief of staff.
Susan C. Winckler has been named the agency’s acting chief of staff. Winckler replaces Patrick Ronan who announced his resignation after several years of service at the FDA. In her new role, Susan will coordinate staff activities in the Office of the Commissioner and serve as the principal liaison to the Department of health and Human services. Susan joined FDA in September 2006 as the director of policy communications, in the Office of Policy and Planning within the Office of the Commissioner.
Dr. Blair Fraser has been selected as division director, Division of Pre-marketing Assessment I, Office of New Drug Quality Assessment (ONDQA). In 2004, Fraser joined Office of New Drug Chemistry and served as deputy director in division 2, and since November 2005 he has worked as chief, Branch II, Division of Pre-marketing Assessment I, ONDQA.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
